Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith S Kaye

Showing results (301-310 of 421) with videos related to

Pageof 43
Sort By:
The Lancet. Infectious Diseases|October 15, 2020
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trialRichard G Wunderink, Yuko Matsunaga, Mari Ariyasu, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activityJustin R Lenhard, Visanu Thamlikitkul, Fernanda P Silveira, et al.
Open Forum Infectious Diseases|April 27, 2019
Implementation and Impact of an Antimicrobial Stewardship Program at a Tertiary Care Center in South IndiaSanjeev Singh, Vidya P Menon, Zubair U Mohamed, et al.
Infection Control and Hospital Epidemiology|July 4, 2017
The Effect of Adding Comorbidities to Current Centers for Disease Control and Prevention Central-Line-Associated Bloodstream Infection Risk-Adjustment MethodologySarah S Jackson, Surbhi Leekha, Laurence S Magder, et al.
Infection Control and Hospital Epidemiology|June 4, 2010
Variation in the type and frequency of postoperative invasive Staphylococcus aureus infections according to type of surgical procedureDeverick J Anderson, Jean Marie Arduino, Shelby D Reed, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2013
Consistent global approach on reporting of colistin doses to promote safe and effective useRoger L Nation, Jian Li, Otto Cars, et al.
Open Forum Infectious Diseases|November 8, 2018
Epidemiology of Diabetic Foot Infection in the Metro-Detroit Area With a Focus on Independent Predictors for Pathogens Resistant to Recommended Empiric Antimicrobial TherapyOryan Henig, Jason M Pogue, Raymond Cha, et al.
Infection Control and Hospital Epidemiology|May 21, 2015
Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing EnterobacteriaceaeHadas Ofer-Friedman, Coral Shefler, Sarit Sharma, et al.
Infection Control and Hospital Epidemiology|July 16, 2005
Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysisJohn J Engemann, Joelle Y Friedman, Shelby D Reed, et al.
JAMA Internal Medicine|August 27, 2019
Risk Factors and Outcomes Associated With Treatment of Asymptomatic Bacteriuria in Hospitalized PatientsLindsay A Petty, Valerie M Vaughn, Scott A Flanders, et al.
Pageof 43

Showing results (301-310 of 421) with videos related to

Sort By:
Pageof 43
The Lancet. Infectious Diseases|October 15, 2020
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trialRichard G Wunderink, Yuko Matsunaga, Mari Ariyasu, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activityJustin R Lenhard, Visanu Thamlikitkul, Fernanda P Silveira, et al.
Open Forum Infectious Diseases|April 27, 2019
Implementation and Impact of an Antimicrobial Stewardship Program at a Tertiary Care Center in South IndiaSanjeev Singh, Vidya P Menon, Zubair U Mohamed, et al.
Infection Control and Hospital Epidemiology|July 4, 2017
The Effect of Adding Comorbidities to Current Centers for Disease Control and Prevention Central-Line-Associated Bloodstream Infection Risk-Adjustment MethodologySarah S Jackson, Surbhi Leekha, Laurence S Magder, et al.
Infection Control and Hospital Epidemiology|June 4, 2010
Variation in the type and frequency of postoperative invasive Staphylococcus aureus infections according to type of surgical procedureDeverick J Anderson, Jean Marie Arduino, Shelby D Reed, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2013
Consistent global approach on reporting of colistin doses to promote safe and effective useRoger L Nation, Jian Li, Otto Cars, et al.
Open Forum Infectious Diseases|November 8, 2018
Epidemiology of Diabetic Foot Infection in the Metro-Detroit Area With a Focus on Independent Predictors for Pathogens Resistant to Recommended Empiric Antimicrobial TherapyOryan Henig, Jason M Pogue, Raymond Cha, et al.
Infection Control and Hospital Epidemiology|May 21, 2015
Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing EnterobacteriaceaeHadas Ofer-Friedman, Coral Shefler, Sarit Sharma, et al.
Infection Control and Hospital Epidemiology|July 16, 2005
Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysisJohn J Engemann, Joelle Y Friedman, Shelby D Reed, et al.
JAMA Internal Medicine|August 27, 2019
Risk Factors and Outcomes Associated With Treatment of Asymptomatic Bacteriuria in Hospitalized PatientsLindsay A Petty, Valerie M Vaughn, Scott A Flanders, et al.
Pageof 43